We are live on ! Find out more
DBIA

Dumont & Blake Investment Advisors Portfolio holdings

AUM $445M
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
+9.36%
1 Year Est. Return
+31.98%
3 Year Est. Return
+78.27%
5 Year Est. Return
+88.91%
10 Year Est. Return
+293.66%
AUM
$384M
AUM Growth
+$33.9M
Cap. Flow
+$3.91M
Cap. Flow %
1.02%
Top 10 Hldgs %
34.88%
Holding
214
New
5
Increased
119
Reduced
55
Closed
4

Sector Composition

Rank Sector Weight
1 Technology 13.03%
2 Financials 8.04%
3 Consumer Discretionary 7.83%
4 Healthcare 6.94%
5 Industrials 4.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDY icon
26
State Street SPDR S&P Dividend ETF
SDY
$22.1B
$3.26M 0.85%
25,227
+1,177
+5% +$146K
JPM icon
27
JPMorgan Chase
JPM
$950B
$3.09M 0.8%
19,504
-148
-0.8% -$24.3K
XLB icon
28
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
$3.08M 0.8%
68,060
+342
+0.5% +$14.8K
XLK icon
29
State Street Technology Select Sector SPDR ETF
XLK
$123B
$3.05M 0.8%
35,136
+1,800
+5% +$148K
CSCO icon
30
Cisco
CSCO
$479B
$3M 0.78%
47,334
+1,135
+2% +$64.8K
ABBV icon
31
AbbVie
ABBV
$435B
$2.79M 0.73%
20,588
+373
+2% +$44.1K
MET icon
32
MetLife
MET
$62.1B
$2.77M 0.72%
44,370
+152
+0.3% +$9.54K
IBM icon
33
IBM
IBM
$224B
$2.73M 0.71%
20,435
-800
-4% -$100K
IJK icon
34
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
$2.72M 0.71%
31,885
+386
+1% +$32.4K
WMT icon
35
Walmart Inc
WMT
$890B
$2.55M 0.66%
52,848
-189
-0.4% -$9.02K
PG icon
36
Procter & Gamble
PG
$339B
$2.55M 0.66%
15,562
+389
+3% +$57.8K
PEP icon
37
PepsiCo
PEP
$190B
$2.52M 0.66%
14,497
+41
+0.3% +$6.7K
AMGN icon
38
Amgen
AMGN
$222B
$2.47M 0.64%
10,982
+37
+0.3% +$7.81K
IWP icon
39
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$2.32M 0.6%
20,111
+281
+1% +$32.8K
TGT icon
40
Target
TGT
$68B
$2.28M 0.6%
9,870
+5
+0.1% +$1.22K
SYF icon
41
Synchrony
SYF
$25.6B
$2.18M 0.57%
47,027
+75
+0.2% +$3.61K
SJNK icon
42
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.8B
$2.17M 0.57%
80,017
+3,253
+4% +$88.4K
XOM icon
43
ExxonMobil
XOM
$634B
$2.13M 0.56%
34,827
-262
-0.7% -$16.4K
XLC icon
44
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
$2.12M 0.55%
27,241
+1,571
+6% +$124K
APD icon
45
Air Products & Chemicals
APD
$67.6B
$2.11M 0.55%
6,944
-8
-0.1% -$2.35K
LLY icon
46
Eli Lilly
LLY
$1.06T
$2.08M 0.54%
7,550
MRSH
47
Marsh
MRSH
$91.5B
$2.08M 0.54%
11,970
-66
-0.5% -$11K
VPU
48
Vanguard Utilities ETF
VPU
$8.44B
$2.05M 0.54%
13,131
+118
+0.9% +$17.4K
IJJ icon
49
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9.03B
$2M 0.52%
18,088
+241
+1% +$26.2K
FDN icon
50
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.34B
$2M 0.52%
8,843
+105
+1% +$24.9K

Similar funds

Dumont & Blake Investment Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Dumont & Blake Investment Advisors held 214 positions worth $384M, up 9.7% from $350M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 4.2%. Dumont & Blake Investment Advisors opened 5 new positions and exited 4, leaving the 214-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Dumont & Blake Investment Advisors's largest Q4 2021 buy was Filana Therapeutics: 6,000 shares worth $262K.
  • Dumont & Blake Investment Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $397K increase.
  • Dumont & Blake Investment Advisors's biggest Q4 2021 reduction was Tesla, cutting an estimated $302K.
  • Dumont & Blake Investment Advisors fully exited Take-Two Interactive in Q4 2021, selling an estimated $616K.
  • Dumont & Blake Investment Advisors's ten largest holdings make up 35% of its $384M portfolio in Q4 2021.
  • Dumont & Blake Investment Advisors opened 5 new positions and closed 4 in Q4 2021.
  • Dumont & Blake Investment Advisors's portfolio value rose 9.7% quarter-over-quarter to $384M.

Based on Dumont & Blake Investment Advisors's 13F filing for Q4 2021, filed 31 Jan 2022.